Therapy News and Research

RSS

Switching treatment to the drug anastrozole after two years of tamoxifen is beneficial for women with early breast cancer

Switching treatment to the drug anastrozole after two years of tamoxifen can improve eventfree survival for postmenopausal women with early breast cancer, concludes a study in this week’s issue of The Lancet.

4 Aug 2005

Hormone replacement therapy and breast cancer

A woman's risk of developing breast cancer while taking hormone replacement therapy may be lower than we think, suggest researchers in this week’s British Medical journal (BMJ).

4 Aug 2005

Cognitive therapy can have a preventive effect for depression

Three years ago, Terry Tuton was laid off from his job as project manager at a large technology firm, leaving him limited insurance coverage at a time when he was suffering from overpowering feelings of hopelessness and depression - and not for the first time in his life.

4 Aug 2005

Discovery may lead to new diagnostic tests for immunoglobulin A (IgA) deficiency and common variable immunodeficiency (CVID)

Defects in a single gene can result in two immune system disorders that leave affected individuals vulnerable to frequent or unusually severe infections, according to new findings reported in the August issue of Nature Genetics.

4 Aug 2005

Hot flashes - women experience this symptom differently

Hot flashes are well known to most menopausal women - and to many who are in perimenopause, the transition to menopause.

4 Aug 2005

Not enough women take part in heart drug trials

Scientists say because women are under-represented in the clinical trials of heart drugs, doctors are left in the dark as to how treatments may work differently in their bodies.

3 Aug 2005

Breed and placement affect skin drug delivery

Skin creams and patches might be the easiest way to give your pets medicine but their success also depends on the breed and where it’s applied.

2 Aug 2005

Study addresses critical GVHD complication - limitations of bone marrow transplants

Together with 16 other institutions in the United States, University of Minnesota researchers led the largest study to date in patients with leukemia and related disorders undergoing bone marrow transplantation from unrelated donors.

2 Aug 2005

Scientists use gene transfer to prevent retinoschisis

University of Florida scientists used a healthy human gene to prevent blindness in mice with a form of an incurable eye disease that strikes boys.

2 Aug 2005

Cognitive therapy programs help prevent repeat suicides attempts

Adults who had attempted suicide reduced their risk of a repeat attempt by participating in a cognitive therapy program, compared to adults who received the usual care, according to a study in the August 3 issue of JAMA: The Journal of the American Medical Association, a theme issue on violence and human rights.

2 Aug 2005

Guidant receives FDA approval to re-enter heart failure market

Guidant Corporation has announced U.S. Food and Drug Administration (FDA) approval to re-launch its CONTAK RENEWAL 3 family of cardiac resynchronization therapy (CRT) defibrillators in the United States.

2 Aug 2005

Strategic analyses of European In-Vitro cancer diagnostics market - Cancer research yields promising results

Every year, nearly one in four Europeans - a total of almost one million people - dies from cancer, giving Europe the dubious distinction of having amongst the highest cancer-related mortality rates in the world. Even as cancer remains a difficult disease to diagnose, often resulting in either poor diagnosis or misdiagnosis, the number of new cancer cases is set to double by 2020.

2 Aug 2005

HAART reduces AIDS rates by 86%

Highly active antiretroviral therapy (HAART) for HIV-infected individuals has reduced the rate of progression to AIDS or death by 86%, according to new research from Bristol University published in The Lancet.

2 Aug 2005

Signs of atherosclerosis seen in apparently healthy young adults

Young adults who seem to be healthy, but have a clustering of heart disease risks factors known as metabolic syndrome, tend to have signs of thickening of their carotid artery walls, which is an early indication of atherosclerosis, according to a new study in the Aug 2, 2005, issue of the Journal of the American College of Cardiology.

2 Aug 2005

Communication from physicians and health care teams needs to improve to meet patient's needs

Researchers report in the current issue of Mayo Clinic Proceedings that more than one-half of their study patients were unable to list their medications, diagnoses, treatment plan (names and purposes of medications) and common side effects of prescribed medications.

2 Aug 2005

Drugs with similar chemical attributes as Ecstasy might offer useful alternatives to current therapies for Parkinson's disease

Amphetamines, including the drug popularly known as Ecstasy, can reverse the symptoms of Parkinson's disease in mice with an acute form of the condition, according to new research at Duke University Medical Center.

2 Aug 2005

Protein called cyclin D1 disrupts BRCA1's normal role as a cancer inhibitor

For about a decade, scientists have recognized that many cases of hereditary breast cancer result from a mutation of a specific gene called BRCA1, which, in its normal state, helps keep tumor formation in check. About five to 10 percent of breast cancer cases are linked to genetic miscues, about half of which are linked to BRCA1.

2 Aug 2005

New laser therapy that destroys cancer cells but leaves healthy ones unharmed

Scientists at Stanford University have developed a new laser therapy that destroys cancer cells but leaves healthy ones unharmed. The new, non-invasive treatment is described in a study published in the Aug. 1 online edition of the Proceedings of the National Academy of Sciences (PNAS).

2 Aug 2005

Radiation helps eye cancer patients retain vision

Doctors in the United Kingdom have determined that patients suffering from cancer affecting their eye can usually avoid visual handicap, loss of the eye and spread of the disease by receiving proton beam radiation therapy, according to a new study

1 Aug 2005

People with HIV in developing countries do just as well on antiretroviral therapy (ART) programs as do people with HIV on ART programs in developed countries

It also shows that people with HIV who are given free ART drugs will do "significantly" better at fighting the disease compared to those who must pay for the drugs.

1 Aug 2005

Therapy News and Research

Switching treatment to the drug anastrozole after two years of tamoxifen is beneficial for women with early breast cancer

Hormone replacement therapy and breast cancer

Cognitive therapy can have a preventive effect for depression

Discovery may lead to new diagnostic tests for immunoglobulin A (IgA) deficiency and common variable immunodeficiency (CVID)

Hot flashes - women experience this symptom differently

Not enough women take part in heart drug trials

Breed and placement affect skin drug delivery

Study addresses critical GVHD complication - limitations of bone marrow transplants

Scientists use gene transfer to prevent retinoschisis

Cognitive therapy programs help prevent repeat suicides attempts

Guidant receives FDA approval to re-enter heart failure market

Strategic analyses of European In-Vitro cancer diagnostics market - Cancer research yields promising results

HAART reduces AIDS rates by 86%

Signs of atherosclerosis seen in apparently healthy young adults

Communication from physicians and health care teams needs to improve to meet patient's needs

Drugs with similar chemical attributes as Ecstasy might offer useful alternatives to current therapies for Parkinson's disease

Protein called cyclin D1 disrupts BRCA1's normal role as a cancer inhibitor

New laser therapy that destroys cancer cells but leaves healthy ones unharmed

Radiation helps eye cancer patients retain vision

People with HIV in developing countries do just as well on antiretroviral therapy (ART) programs as do people with HIV on ART programs in developed countries

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News